Occupant of heavy transport vehicle injured in other and unspecified transport accidents

VWXY20_OCCUPANT_HEAVY_TRANSPO_VEHIC_INJURED_OTHER_UNSPE_TRANSPO_ACCIDENTS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — V69 Cause of death: ICD-10 — V69 2 out of 7 registries used, show all original rules.	204
4. Check minimum number of events None	204
5. Include endpoints None	204
6. Filter based on genotype QC (FinnGen only)	204

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: V29|V[3-8]

NAME	VWXY20_OCCUPANT_HEAVY_TRANSPO_VEHIC_INJURED_OTHER_UNSPE_TRANSPO_ACCIDENTS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	V69
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	V69
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Occupant of heavy transport vehicle injured in other and unspecified transport accidents based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	204	28	176
Unadjusted period prevalence (%)	0.07	0.01	0.08
Median age at first event (years)	43.00	37.23	43.92

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
185: Matched controls
1851

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

V69.9

ICD-10 Finland

Occupant [any] of heavy transport vehicle injured in unspecified traffic accident

+∞

174.9

139

V69.2

ICD-10 Finland

Unspecified occupant of heavy transport vehicle injured in collision with other and unspecified motor vehicles in nontraffic accident

+∞

53.8

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

10.2

14.6

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

9.6

11.4

S06.0

ICD-10 Finland

Concussion

4.7

10.9

100

NA1AD

NOMESCO Finland

Cervical spine CT examination

9.3

10.4

S22.3

ICD-10 Finland

Fracture of rib

5.6

9.6

JN5BD

NOMESCO Finland

Head and body CT examination for trauma

18.8

9.6

S20.2

ICD-10 Finland

Contusion of thorax

6.3

8.5

S06.2

ICD-10 Finland

Diffuse brain injury

15.9

7.8

T90.5

ICD-10 Finland

Sequelae of intracranial injury

15.9

7.8

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

11.5

7.4

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

6.8

7.1

S22.4

ICD-10 Finland

Multiple fractures of ribs

9.9

6.9

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.3

6.7

586

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

7.3

6.7

N02AX02

ATC

tramadol; systemic, rectal

2.3

6.6

474

AA1AD

NOMESCO Finland

CT of head and brain

2.8

6.6

194

W31

ICD-10 Finland

Contact with other and unspecified machinery

6.7

6.3

V69

ICD-10 Finland

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

+∞

6.3

N03AX12

ATC

gabapentin; oral

3.2

6.2

113

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

584

2.05

5.82

3.7

3.3

25.05

44.20

ng/l

1.30

366

(3021901) Oxygen saturation in Capillary blood

5.21

4.83

1.7

1.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

124

920

1.89

4.59

6.1

5.5

7.14

6.74

mmol/l

0.91

117

863

(3032080) INR in Blood by Coagulation assay

598

1.79

3.95

6.3

7.6

1.21

inr

0.01

170

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

199

1.98

3.16

3.6

2.2

21.95

25.25

0.66

180

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

333

1.80

3.15

1.7

1.8

1.04

1.26

mg/l

0.44

254

(3022621) pH of Urine by Test strip

2.64

3.13

2.8

1.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

680

1.61

2.80

4.4

4.2

—

(3042936) Bacteria identified in Isolate by Culture

233

1.83

2.71

2.2

2.5

—

(3023368) Bacteria identified in Blood by Culture

415

1.67

2.71

3.7

4.6

—

(3029937) Albumin [Presence] in Urine by Test strip

373

1.69

2.69

3.9

3.1

0.00

0.01

estimate

0.50

124

(3026008) Bacteria identified in Urine by Culture

282

1.76

2.68

3.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

173

1.93

2.65

21.3

20.2

1.59

1.16

inr

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

579

1.59

2.59

3.6

3.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

654

1.58

2.55

10.3

8.4

1.19

1.20

mmol/l

0.63

572

(3007853) Bacteria identified in Skin by Aerobe culture

192

1.86

2.49

1.8

1.7

—

(3013512) EKG study

406

1.64

2.48

4.6

3.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2.15

2.30

2.7

3.7

1.22

mmol/l

0.13

(3035350) Ketones [Presence] in Urine by Test strip

716

1.52

2.24

3.3

3.1

0.00

estimate

0.00

130

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

2.87

2.23

1.6

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

3.78

2.17

1.0

1.8

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

2.46

2.17

6.5

15.2

0.72

0.93

1.47

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2.30

2.17

4.4

4.1

54.43

58.19

0.21

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

4.38

2.16

1.0

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

455

1.56

2.14

2.9

2.4

—

(40761536) Microorganisms panel - Urine sediment

112

1.98

2.05

3.0

3.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2.59

2.05

2.2

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

3.16

2.03

1.1

2.3

—

(3009261) Glucose [Presence] in Urine by Test strip

727

1.48

2.03

3.4

3.1

0.00

estimate

0.00

123

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2.33

1.95

6.5

14.5

1.54

1.62

0.15

(3020682) Albumin/Creatinine [Ratio] in Urine

455

1.52

1.94

5.6

4.3

22.07

9.97

mg/mmol

0.40

314

(3008152) Bicarbonate [Moles/volume] in Arterial blood

101

1.97

1.88

9.3

12.2

25.12

24.06

mmol/l

0.86

(3021788) Differential panel - Synovial fluid

3.60

1.85

1.2

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

179

1641

1.74

1.84

16.6

12.8

22.70

24.45

mg/l

0.31

154

1287

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

2.83

1.81

1.1

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2.42

1.81

2.5

2.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2.57

1.76

1.2

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

3.40

1.76

1.0

1.5

1.63

1.61

mmol/l

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

134

1.81

1.75

3.1

2.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

1.73

0.0

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

716

1.43

1.72

4.3

4.4

0.00

estimate

0.00

129

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

223

1.63

1.71

1.7

1.9

—

(3022313) Gas panel - Capillary blood

2.01

1.70

5.7

2.5

—

(3019060) Gas panel - Arterial blood

105

1.89

1.69

6.4

9.0

—

(1616796) Gas panel - Central venous blood

2.64

1.67

1.3

2.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

414

1.49

1.67

2.5

373.09

6694.79

umol/l

1.56

363

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

3.22

1.67

1.0

1.9

—

(3019150) Specific gravity of Urine by Refractometry

318

1.53

1.66

3.9

3.1

1.02

kg/l

—

(3012516) Albumin [Mass/volume] in Urine

425

1.47

1.63

4.8

3.5

97.32

218.54

mg/l

0.36

295

(3045414) Leukocytes [Presence] in Urine

2.34

1.56

1.3

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.93

1.55

1.6

1.4

—

(3016879) Cocaine [Presence] in Urine

101

1.86

1.54

2.5

2.4

—

(3000330) Specific gravity of Urine by Test strip

2.14

1.52

2.9

4.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

2.91

1.51

1.2

1.3

—

(3000850) Epithelial cells [#/volume] in Urine

282

1.52

1.49

3.5

2.3

4.19

3.15

e6/l

0.34

251

(3051387) C reactive protein [Mass/volume] in Capillary blood

2.55

1.46

5.7

3.1

51.86

23.87

mg/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

418

1.43

1.42

2.7

2.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

519

1.40

1.7

93.23

95.14

pmol/l

0.13

284

(3037467) Urinalysis macro (dipstick) panel - Urine

116

1002

1.37

1.38

4.5

3.9

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

2.99

1.36

1.4

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

2.99

1.36

1.4

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

262

1.50

1.36

1.8

400.87

428.33

pmol/l

0.30

230

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

288

1.48

1.35

4.2

3.4

156.17

715.75

ng/l

0.94

214

(3012544) pH of Venous blood

138

1.67

1.33

5.6

4.1

—

(3009508) Creatinine [Moles/volume] in Urine

496

1.39

1.32

4.8

3.4

9.65

9.22

mmol/l

0.23

426

(3021879) Hepatitis B virus core Ab [Presence] in Serum

157

0.49

1.31

1.0

1.6

—

(40761535) Cells panel - Urine sediment

107

1.75

1.31

5.7

3.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

2.14

1.30

2.3

2.1

27.60

95.78

ug/min

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

205

1.54

1.29

9.5

6.9

1.06

1.00

mmol/l

0.43

194

(3024522) Salmonella sp identified in Specimen by Organism specific culture

2.82

1.29

1.4

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

2.82

1.29

1.4

1.6

—

(3044941) Cell count panel - Synovial fluid

2.82

1.29

1.2

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

2.15

1.20

1.3

—

(3027008) Opiates [Presence] in Urine

111

1.68

1.16

2.5

2.3

—

(3027944) Amphetamines [Presence] in Urine

111

1.68

1.16

2.5

2.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

104

1.69

1.13

1.6

—

(3028300) Cannabinoids [Presence] in Urine

112

1.67

1.13

2.6

2.3

—

(3018095) Leukocytes [#/volume] in Urine

490

1.35

1.12

3.7

3.3

21.51

121.15

e6/l

0.92

353

(3038515) Glucose [Moles/volume] in Venous blood

2.30

1.11

3.3

3.8

7.91

7.44

mmol/l

—

(3045424) Erythrocytes [Presence] in Urine

2.41

1.09

1.4

1.3

—

(3037756) Immunofixation for Serum or Plasma

2.41

1.09

1.0

1.2

—

(3019225) pH of Specimen

114

1.63

1.07

13.0

4.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2.10

1.04

1.4

1.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

525

1.32

1.01

4.3

2.9

—

(3018572) Chloride [Moles/volume] in Blood

2.03

1.01

9.3

20.1

105.00

104.50

mmol/l

—

(3039000) Anion gap in Blood

2.03

1.01

9.3

20.1

9.43

11.47

mmol/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.98

0.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.98

0.0

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

0.00

0.98

0.0

5.4

—

359.64

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

133

1206

1.30

0.97

8.7

7.7

78.15

75.28

u/l

0.57

128

1144

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

353

1.35

0.96

3.0

2.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.96

0.0

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

1.80

0.96

5.9

3.9

3.80

3.93

mmol/l

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1.92

0.95

1.1

1.0

—

165.98

—

(3002582) Erythrocytes [#/volume] in Urine

437

1.32

0.94

3.7

2.9

27.14

210.84

e6/l

0.66

333

(3030467) Casts [#/volume] in Urine by Automated count

392

1.33

0.92

3.2

2.8

0.56

0.41

e6/l

0.15

289

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

104

0.47

0.92

1.4

2.0

197.40

235.77

pmol/l

—

(3025159) Blasts/100 leukocytes in Blood

119

1.56

0.91

3.9

4.4

0.00

0.03

—

(3000764) Benzodiazepines [Presence] in Urine

111

1.58

0.91

2.6

2.3

—

(1761868) Lipid panel - Serum or Plasma

714

0.77

0.89

2.4

2.6

—

(3020891) Body temperature

1.76

0.88

6.6

4.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2.03

0.87

1.3

1.4

—

(3018418) pH of Serum or Plasma

386

1.32

0.87

4.0

3.6

7.40

0.04

(3004588) Protein electrophoresis panel - Serum or Plasma

1.71

0.87

1.3

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

163

1.46

0.86

1.3

1.8

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

307

1.33

0.82

1.8

2.3

1.36

1.49

0.45

280

(40758558) Short blood count panel - Blood

381

1.30

0.81

3.9

6.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

123

1.51

0.81

4.1

4.5

0.00

0.28

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

100

0.49

0.79

2.0

2.3

—

5.87

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.79

0.0

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.79

0.0

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.79

0.0

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.79

0.0

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.79

0.0

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.79

0.0

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.79

0.0

1.3

—

(3003694) ABO and Rh group [Type] in Blood

429

1.28

0.78

1.4

1.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

176

1.41

0.77

6.3

12.6

11.40

12.77

kpa

1.20

169

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

176

1.41

0.77

6.3

12.7

5.22

5.10

kpa

0.39

168

(3012501) Base excess in Blood by calculation

1.79

0.77

1.8

2.4

2.10

2.19

mmol/l

—

(3027315) Oxygen [Partial pressure] in Blood

1.79

0.77

1.8

2.4

9.40

8.82

kpa

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.79

0.77

1.0

1.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1.79

0.77

1.8

2.4

5.25

5.04

kpa

—

(3000991) Gas panel - Venous blood

134

0.58

0.76

8.1

10.5

—

(3035285) Chloride [Moles/volume] in Venous blood

2.11

0.75

1.4

2.7

103.80

105.88

mmol/l

—

(3041354) Potassium [Moles/volume] in Venous blood

2.11

0.75

1.4

2.7

4.22

4.11

mmol/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

2.11

0.75

1.4

2.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

227

0.68

0.73

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

101

1.52

0.72

3.7

4.0

138.13

132.79

g/l

0.44

101

(3017181) Myelocytes/100 leukocytes in Blood

135

1.45

0.72

3.9

4.4

0.75

1.07

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1.78

0.72

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

0.52

0.68

1.2

1.1

—

13.96

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.55

0.68

3.2

2.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

410

1.26

0.66

1.5

1.7

1.70

1.48

mmol/l

0.55

348

(3002173) Hemoglobin [Mass/volume] in Arterial blood

155

1.40

0.66

6.9

13.5

129.14

125.35

g/l

0.28

148

(3017732) Neutrophils [#/volume] in Blood

112

1.47

0.66

1.8

2.7

4.60

4.01

e9/l

0.55

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

364

1.27

0.65

1.3

1.2

0.74

1.22

u/ml

1.35

102

(3036481) Cortisol [Moles/volume] in Serum or Plasma

148

1.39

0.62

2.3

2.2

277.80

371.59

nmol/l

1.26

136

(3019832) Treponema pallidum Ab [Presence] in Serum

148

1.39

0.62

2.1

1.8

—

(4306422)

1.68

0.62

1.4

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

166

1.36

0.62

1.3

1.8

—

(3018010) Neutrophils/100 leukocytes in Blood

760

1.20

0.61

6.1

5.8

59.53

56.92

1.53

728

(3013650) Neutrophils [#/volume] in Blood by Automated count

100

909

1.20

0.60

8.1

9.2

4.60

4.13

e9/l

1.19

790

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.59

0.0

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

150

1.37

0.58

2.3

2.6

1.86

1.87

0.01

138

(21494755) Public health laboratory ask at order entry panel

272

0.75

0.58

1.2

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.54

0.57

2.0

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

333

1.25

0.57

1.4

1.3

2.37

2.53

g/l

0.45

220

(3021589) Normoblasts [#/volume] in Blood

697

1.19

0.56

10.1

8.9

0.00

e9/l

0.53

559

(1761482) Bacteria [#/volume] in Urine by Culture

1.60

0.55

2.7

5.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

126

1.38

0.53

4.1

4.0

0.00

0.52

—

(3009542) Hematocrit [Volume Fraction] of Blood

168

1611

1.24

0.53

11.5

13.2

39.19

41.98

1.74

125

1292

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.40

0.51

1.4

—

(3019198) Lymphocytes [#/volume] in Blood

811

1.17

0.50

6.2

6.0

1.83

1.92

e9/l

0.42

725

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

510

0.83

0.50

2.1

2.6

0.50

0.68

ug/l

2.57

288

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.57

0.49

1.1

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

1.51

0.48

2.3

3.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

156

1.31

0.47

10.2

8.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

103

1.39

0.46

1.4

1.5

0.98

1.32

g/l

0.62

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

314

1.22

0.45

1.3

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.47

0.45

1.1

1.2

—

(40768797) Stomach Pathology biopsy report

185

1.27

0.44

1.2

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

231

1.25

0.44

1.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

113

1.35

0.44

1.9

2.4

92.80

69.02

ml/min/173m2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

872

0.86

0.43

4.2

3.9

1.77

2.18

ug/l

0.42

789

(4034850)

1.45

0.43

4.5

12.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

216

0.77

0.43

1.4

1.7

—

(36304419) Bacteria [Presence] in Urine

373

1.19

0.42

3.0

2.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.58

0.42

2.4

3.4

—

1096.17

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.41

0.0

7.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.41

0.0

3.9

—

(3008295) Osmolality of Serum or Plasma

0.00

0.41

0.0

1.2

—

278.27

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.41

0.0

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

162

1560

1.19

0.41

13.6

11.3

89.16

88.64

ml/min/173m2

0.10

138

1278

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.00

0.41

0.0

10.6

—

36.44

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1.48

0.40

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.40

0.0

4.3

—

(3051651) Icteric interference index of Serum or Plasma

0.00

0.40

0.0

2.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

156

1499

1.17

0.40

8.1

5.3

41.53

40.06

mmol/mol

0.94

148

1409

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

144

1377

1.16

0.39

4.1

3.9

1.69

1.88

mu/l

1.51

136

1280

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

162

1564

1.17

0.37

4.9

4.1

6.27

6.03

mmol/l

1.31

155

1442

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.64

0.36

3.8

2.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

0.62

0.36

1.6

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.39

0.35

1.8

1.5

—

(3025941) Bacteria identified in Stool by Culture

1.36

0.35

1.4

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.37

0.34

1.3

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

115

1089

1.13

0.34

3.5

3.2

14.81

14.65

pmol/l

0.27

106

988

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

0.66

0.33

3.7

3.6

4.62

4.58

pmol/l

—

(3037522) Nuclear Ab [Titer] in Serum

211

1.21

0.33

1.3

1.4

200.00

325.00

titre

—

(3006504) Eosinophils/100 leukocytes in Blood

742

1.13

0.33

6.4

6.0

2.92

2.90

0.03

703

(1002224) Polysomnography panel

0.70

0.31

1.0

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1.33

0.31

1.9

1.6

—

0.08

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.33

0.31

1.9

1.7

—

(3013115) Eosinophils [#/volume] in Blood

810

1.11

0.26

6.4

6.5

0.21

0.20

e9/l

0.37

726

(3039443) Prostate specific Ag panel - Serum or Plasma

0.66

0.26

1.4

1.6

—

(3006315) Basophils [#/volume] in Blood

792

1.10

0.25

6.5

5.9

0.04

e9/l

0.47

692

(40760892) CBC W Ordered Manual Differential panel - Blood

372

1.13

0.24

3.8

4.6

—

(3013707) Erythrocyte sedimentation rate by Westergren method

115

1103

1.10

0.24

4.6

3.6

12.15

9.21

mm/h

1.58

110

1034

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.26

0.23

7.9

18.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

116

1205

0.91

0.23

3.0

3.1

—

(4035726)

107

1.23

0.22

1.2

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

165

1685

0.89

0.22

4.6

4.1

1.26

1.32

mmol/l

1.37

159

1566

(3005322) IgE [Units/volume] in Serum or Plasma

103

0.77

0.21

1.5

1.2

205.84

246.15

u/ml

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.20

0.21

1.4

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.00

0.21

0.0

3.4

—

(40768795) Lymph node Pathology biopsy report

0.00

0.21

0.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

(4027681)

0.00

0.21

0.0

1.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

0.00

0.21

0.0

1.2

—

63.44

—

(3045788) Cell count panel - Pleural fluid

0.00

0.21

0.0

1.7

—

(3026470) Cobalt [Mass/volume] in Blood

0.00

0.21

0.0

1.9

—

4.11

—

(4024509)

0.00

0.21

0.0

1.5

—

(3025577) Chromium [Mass/volume] in Blood

0.00

0.21

0.0

1.9

—

2.04

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.21

0.0

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

691

0.91

0.21

3.6

3.7

19.57

21.16

0.47

290

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.5

—

1.76

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

0.00

0.21

0.0

3.1

—

11.00

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.21

0.0

1.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

202

1.16

0.21

5.1

8.8

104.70

103.91

mmol/l

0.63

196

(3015183) Erythrocyte sedimentation rate

0.00

0.21

0.0

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.20

0.0

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.20

0.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.23

0.20

1.8

1.6

—

(3002256) Pathology report gross observation

156

1.17

0.19

1.1

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.16

0.19

3.2

2.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

321

1.11

0.18

4.3

3.0

—

(40761511) CBC panel - Blood by Automated count

179

1763

1.12

0.17

16.7

11.6

—

(3008898) HLA-B27 [Presence]

1.18

0.17

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

1.13

0.15

4.1

3.9

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

161

1638

0.92

0.15

4.2

3.7

1.66

1.40

mmol/l

1.81

153

1522

(3044889) 12 lead EKG panel

112

1087

1.07

0.15

3.9

3.5

—

(3001604) Monocytes [#/volume] in Blood

788

1.07

0.14

6.4

5.9

0.62

0.59

e9/l

0.51

684

(3000492) Spirometry study

212

0.89

0.14

1.5

1.4

—

(4010399)

122

1.16

0.14

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

138

0.86

0.13

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

220

1.10

0.12

1.7

2.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

169

1712

0.93

0.12

4.9

4.4

2.76

2.83

mmol/l

0.44

159

1592

(3000494) Fungus identified in Specimen by Culture

192

1.10

0.11

1.7

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.14

0.10

1.0

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.14

0.10

1.0

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

360

1.07

0.10

1.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.11

0.10

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

1.09

0.09

5.3

3.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.09

0.09

2.0

2.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

236

0.92

0.08

2.8

2.7

1.53

0.67

e6/l

0.42

130

(3049717) Cytology report of Urine Cyto stain

1.04

0.08

1.2

2.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

225

1.08

0.08

2.5

2.8

1.65

0.98

e6/l

0.33

117

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

0.81

0.07

1.8

2.2

30.50

39.21

u/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

184

0.92

0.07

4.6

4.3

29.42

30.43

0.13

129

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.04

0.07

1.8

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.13

0.07

2.7

9.4

24.86

24.64

mmol/l

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

0.85

0.07

2.9

2.3

—

(3022145) Colonoscopy Study observation

178

1.07

0.06

1.3

—

(42870588) Differential panel, method unspecified - Blood

521

1.02

0.02

7.7

5.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

223

1.04

0.01

1.3

1.2

1.09

4.58

u/ml

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

233

1.03

0.01

1.4

1.3

19.44

23.94

iu/ml

—

(36660697) Celiac disease serology panel - Serum

136

0.95

0.00

1.1

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

246

0.97

0.00

1.8

2.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

179

1.01

0.00

1.1

1.6

—

(40768804) Tissue Pathology biopsy report

514

0.99

0.00

2.3

1.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

103

0.97

0.00

1.4

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

252

0.99

0.00

2.0

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

88.60

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.02

0.00

2.6

1.7

—

(44813793)

0.00

0.0

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

0.00

0.0

1.7

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1.00

0.00

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.0

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

26.82

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

0.00

0.0

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.3

—

(3017704) Immunofixation for Urine

0.00

0.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

0.0

1.0

—

(3003129) Base excess in Capillary blood by calculation

0.00

0.0

1.2

—

0.88

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.0

1.3

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

0.00

0.0

4.1

—

29.29

—

(3006245) CD3-CD19+ cells/100 cells in Blood

0.00

0.0

4.8

—

10.67

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

3.6

—

154.40

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.00

0.0

2.3

—

9161.67

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.7

—

(3044007) Cell count panel - Peritoneal fluid

0.00

0.0

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.91

0.00

2.0

1.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.0

2.1

—

17.88

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.0

—

116.50

—

(3020650) Glucose [Presence] in Urine

0.00

0.0

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.0

1.0

—

(3004451) EKG impression Narrative

0.00

0.0

1.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

4.0

—

103.00

—

(3034770) Mitochondria Ab [Titer] in Serum

0.92

0.00

1.4

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

2.6

—

121.00

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

0.0

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.00

0.0

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.97

0.00

1.0

—

(40758292) HTLV I+II Ab panel - Serum

0.00

0.0

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

0.0

1.2

—

188.33

—

(3000012) Reticulocyte production index

0.00

0.0

1.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

0.00

0.0

1.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

40.42

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.00

0.0

1.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

2.02

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

0.0

1.9

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.7

—

18.12

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

0.0

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.0

1.5

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.0

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.2

—

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_OCCUPANT_HEAVY_TRANSPO_VEHIC_INJURED_OTHER_UNSPE_TRANSPO_ACCIDENTS – Occupant of heavy transport vehicle injured in other and unspecified transport accidents

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Occupant of heavy transport vehicle injured in other and unspecified transport accidents (VWXY20_OCCUPANT_HEAVY_TRANSPO_VEHIC_INJURED_OTHER_UNSPE_TRANSPO_ACCIDENTS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints